Life sciences and healthcare
Brazilian Ministry of Health publishes internal regulations of the Technical Evaluation Commission (CTA) of the Brazilian Health Industrial Complex (Ceis).
ANS opens public consultation on regulatory sandbox to allow development of supplementary health solutions incompatible with current regulations.
National Supplementary Health Agency opens consultation on collective readjustment and outpatient plans. Contributions can be sent until October 31st.
Anvisa opens public consultation that proposes criteria and procedures for the signature of commitment terms for registration and post-registration of medicines.
Map opens public hearing on drone and manned operations, to adjust standards to new technologies and reduce bureaucracy.
In September, the Federal Supreme Court (STF) resumed the trial of two leading cases involving the supply of medicines.
Federal Council of Medicine (CFM) regulates the relationship between doctors and industry. New resolution comes into force in March 2025.
Federal Pharmacy Council regulates pharmaceutical practice in digital health and AI. New regulation allows the prescription of digital therapies.
Anvisa publishes notice for collecting contributions on the regulatory sandbox proposal. Public call of subsidies runs from August 12 to October 11.
Ebook: New rules for public private partnership under the Brazilian Health Industrial Complex (CEIS)
Our updated ebook New Rules for Private Partnerships under the Brazilian Health Industrial Complex (CEIS) details recent public policies issued by the Brazilian Ministry of Health for strengthening the Unified Health System (SUS) industry and innovation.
New regulation from the National Health Surveillance Agency (Anvisa) establishes a pilot project for the gradual implementation of digital drug leaflets.
Anvisa approves the National Prescription Control System to improve, to streamline the numbering and control of prescriptions for controlled-use medications.
